Search clinical trials for: EMS Acarbose
Total 3118 results
-
EMSCompletedType 2 Diabetes MellitusBrazil
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, France
-
Chestnut Health SystemsNational Institute on Drug Abuse (NIDA)CompletedRecovery | Substance Use Disorder (SUD)United States
-
BayerCompletedDiabetes Mellitus, Type 2Germany
-
BayerCompletedDiabetes Mellitus, Type 2Germany
-
BayerCompleted
-
Guiyang Medical UniversityNot yet recruitingHead and Neck Squamous CarcinomaChina
-
Radboud University Medical CenterCompletedType 2 Diabetes | Endothelial DysfunctionNetherlands
-
The Cleveland ClinicCompleted
-
Tioga PharmaceuticalsRTI Health SolutionsCompletedIrritable Bowel SyndromeUnited States
-
The University of Texas Health Science Center at...Completed
-
GWT-TUD GmbHTechnische Universität Dresden; University of Regensburg; Diakonissen Krankenhaus...CompletedType 2 Diabetes Mellitus | Subclinical InflammationGermany
-
GWT-TUD GmbHCompleted
-
Technische Universität DresdenCompleted
-
Aichi Gakuin UniversityUnknownCoronary Artery Disease | Diabetes Mellitus | Impaired Glucose ToleranceJapan
-
AgelessRxCompletedTolerance | Side Effect | Glucose ResponseUnited States
-
BayerCompletedDiabetes MellitusRussian Federation, India, Korea, Republic of, Indonesia, Malaysia, Philippines, Singapore, Thailand, China, Hong Kong, Pakistan, Vietnam, Algeria, Moldova, Republic of, Bosnia and Herzegovina, Cambodia
-
Karolinska InstitutetBayer; The Swedish Research CouncilCompleted
-
Tioga PharmaceuticalsCompleted
-
BayerCompletedDiabetes MellitusKorea, Republic of
-
BayerCompleted
-
BayerCompleted
-
University of Alabama at BirminghamNot yet recruitingKidney CancerUnited States
-
BayerCompleted
-
BayerCompleted
-
Lotus PharmaceuticalUnknownThe Objectives of the Study is to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg | Plus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks in | Subjects With Type 2 Diabetes Mellitus.Taiwan
-
BayerCompleted
-
Riphah International UniversityCompleted
-
Tioga PharmaceuticalsRTI Health SolutionsCompletedDiarrhea Predominant Irritable Bowel SyndromeUnited States
-
He XiaUnknown
-
Inje UniversitySanofiCompletedDiabetes Mellitus | Type 2 Diabetes MellitusKorea, Republic of
-
Royan InstituteCompletedPCOIran, Islamic Republic of
-
BayerActive, not recruiting
-
Charite University, Berlin, Germanymiha bodytec GmbH; Sonnenfeld-Stiftung; Robert-Enke-StiftungActive, not recruiting
-
Hvidovre University HospitalUniversity of CopenhagenCompleted
-
BayerCompleted
-
BayerWithdrawn
-
BayerCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Universidad de LeónCompleted
-
The Catholic University of KoreaBayerCompletedType 2 Diabetes MellitusKorea, Republic of
-
RWTH Aachen UniversityCompleted
-
University Health Network, TorontoThe Lung AssociationCompleted
-
Astellas Pharma IncTerminatedA Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes MellitusType II Diabetes MellitusTaiwan, Korea, Republic of
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2China
-
Prof. Dr. Frank MoorenCompleted
-
University of Erlangen-Nürnberg Medical SchoolUnknownInflammation | Cancer | Muscular Atrophy | Cancer CachexiaGermany
-
Mackay Memorial HospitalTerminatedCritical Illness Myopathy | Chronic Respiratory FailureTaiwan